Altogether, these studies suggest that interactions between tumor-associated carbohydrates antigens (TACAs) and CLRs on DCs are crucial to shape subsequent immune responses, and justify further investigations in melanoma to better understand and exploit the glycan/CLR axis. This evidence concerns the gene LARS1 and neoplasm.